Reports

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

Celgene COO Scott Smith Precipitously Resigns

Celgene has had a rocky last couple of months, with its share price dropping from $146 to $87 since October last year. This time, the blame game seems to fall on Chief Operating Officer, Scott Smith.